Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Clinical trial NCT07193420 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07193420
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

GVHD - Graft-Versus-Host Disease HSCT Haploidentical Stem Cell Transplantation

Start date: 2026-06-01
Primary completion: 2030-06-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.